Name: 글로벌 시장 동향
SKU: MD7597
Availability: InStock

보고서 요약(국문)

개요
전 세계 심부정맥질환 치료기기 시장은 2022년 XX백만 달러에 달했으며, 2023년부터 2030년까지 연평균 XX%의 성장률을 기록하며 2030년에는 XX백만 달러에 이를 것으로 예상됩니다.
심부정맥혈전증(DVT)은 심부정맥, 주로 다리에 발생하는 혈전으로, 팔, 장간막정맥, 뇌정맥에서도 발생할 수 있습니다. 정맥 기능 부전 및 기타 정맥 질환은 급성으로 나타날 수도 있고, 만성 질환으로 수개월 또는 수년간 지속될 수도 있습니다.
심부정맥질환 치료기기는 이러한 정맥 질환 및 혈전을 치료하기 위해 개발되었습니다. 이러한 기기에는 정맥 스텐트, 카테터, 필터, 압박 스타킹 등이 있습니다. 이러한 기기들은 심부정맥질환의 예방 및 관리에 중요한 역할을 합니다.

시장 동향: 성장 동인 및 제약 요인
질병 유병률 증가
고령 인구 증가는 시장 성장을 견인할 것으로 예상됩니다. 나이가 들수록 합병증 발생 위험이 높아집니다. 심부정맥혈전증(DVT)은 모든 연령대에서 발생할 수 있지만 60세 이상 고령층에서 가장 흔합니다. DVT는 심부정맥, 특히 하지에 혈전이 생기는 질환입니다.
폐색전증(PE)은 DVT 혈전의 일부가 떨어져 나와 폐로 이동하는 질환으로 생명을 위협할 수 있습니다. 폐색전증은 혈전이 떨어져 나와 혈류를 통해 폐로 이동할 때 발생합니다.
매년 30만~60만 명의 미국인이 정맥혈전색전증의 영향을 받는 것으로 추정되며, 이는 심장마비와 뇌졸중에 이어 세 번째로 흔한 혈관 질환이자 주요 정형외과 수술로 인한 사망의 주요 원인입니다.

정맥혈전색전증(VTE)은 심부정맥혈전증(DVT)과 폐색전증(PE)을 포함하며, 매년 약 1,000명당 1명꼴로 발생합니다. 발생률은 연령이 증가함에 따라 높아져 80세 이상에서는 1,000명당 최소 5명꼴로 발생합니다. 따라서 이러한 요인들이 시장 성장을 견인할 것으로 예상됩니다.
제약 요인
약물 치료 선호도 증가
약물 치료는 침습적 시술에 비해 여러 대안을 제공하므로 의료기기 수요를 감소시킵니다. 심부정맥질환 환자들은 질환의 심각도에 따라 비용이 많이 드는 시술보다는 빠른 회복을 위해 약물 치료를 선택하는 경우가 많습니다.
세분화 분석
전 세계 심부정맥질환 치료기기 시장은 기기 유형, 최종 사용자 및 지역별로 세분화됩니다.

정맥 스텐트 부문은 시장 점유율 38.4%를 차지했습니다.
기기 기술 발전과 승인 건수 증가로 인해 이 부문은 시장을 주도하는 위치를 유지할 것으로 예상됩니다. 예를 들어, 2023년 1월 페넘브라(Penumbra, Inc.)는 미국 식품의약국(FDA) 승인을 받아 시장에서 가장 발전되고 강력한 기계식 혈전 제거 시스템인 라이트닝 플래시(Lightning Flash)를 출시했습니다. 라이트닝 플래시는 페넘브라의 혁신적인 라이트닝 인텔리전트 흡인(Lightning Intelligent Aspiration) 기술과 이중 혈전 감지 알고리즘을 특징으로 합니다.
2020년 10월 메드트로닉(Medtronic plc)은 아브레(Abre) 정맥 자가팽창형 스텐트 시스템에 대한 미국 식품의약국(FDA) 승인을 받았다고 발표했습니다. 이 기기는 증상이 있는 장골대퇴정맥 유출 폐쇄(심부정맥 폐쇄라고도 함) 환자의 장골대퇴정맥에 사용하도록 적응증이 있습니다. 따라서 위의 요인들이 시장 성장을 견인할 것으로 예상됩니다.

지리적 분석
북미는 전 세계 심부정맥질환 치료기기 시장에서 상당한 점유율을 차지할 것으로 예상됩니다.
기술 발전, 기기 승인 증가, 그리고 이 지역의 심부정맥질환 환자 수 증가가 시장 성장을 견인할 것으로 전망됩니다.
심부정맥혈전증과 폐색전증은 흔한 질환입니다. 미국 국립보건원(NIH)의 2023년 보고서에 따르면, 심부정맥혈전증의 발생률과 유병률은 인구 10만 명당 80건으로 추정되며, 미국에서는 하지 심부정맥혈전증의 유병률이 인구 1,000명당 1건으로 나타났습니다.
미국에서는 매년 20만 명 이상이 정맥혈전증을 앓고 있으며, 이 중 5만 명은 폐색전증으로 합병증이 발생합니다. 따라서 이러한 질환의 유병률 증가는 이 지역 시장 성장을 촉진할 것으로 예상됩니다.

COVID-19 영향 분석
COVID-19는 시장 성장에 중간 정도의 영향을 미쳤습니다. 정부의 봉쇄 조치로 인해 의료기기 제조업체들이 문을 닫았고, 의료 기업들은 COVID-19 치료제 생산에 집중했습니다. 따라서 COVID-19는 시장 성장에 영향을 미쳤습니다.

시장 세분화
기기 유형별
• 절제 기기
• 정맥 스텐트
• 정맥 폐쇄 제품
• 경화 요법 주사
• 대정맥 필터
• 기타
최종 사용자별
• 병원
• 외래 수술 센터
• 기타
지역별
• 북미
o 미국
o 캐나다
o 멕시코
• 유럽
o 독일
o 영국
o 프랑스
o 이탈리아
o 스페인
o 기타 유럽
• 남미
o 브라질
o 아르헨티나
o 기타 남미
• 아시아 태평양
o 중국
o 인도
o 일본
o 호주
o 기타 아시아 태평양
• 중동 및 아프리카
경쟁 환경
주요 기업으로는 Medtronic Plc, Vesper Medical Inc., enVVeno Medical Corporation, Inari Medical, Cook Medical, Boston Scientific Corporation 등이 있으며, 이들 기업은 상당한 시장 점유율을 차지하고 있습니다.
보고서 구매 이유

• 기기 유형, 최종 사용자 및 지역별 글로벌 심부정맥질환 치료기기 시장 세분화를 시각화하고 주요 상업 자산 및 주요 업체를 파악합니다.

• 트렌드 분석 및 공동 개발을 통해 사업 기회를 발굴합니다.

• 모든 세그먼트를 포함한 심부정맥질환 치료기기 시장 수준의 다양한 데이터가 담긴 엑셀 자료를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석 결과를 담은 PDF 보고서를 제공합니다.

• 주요 업체들의 핵심 제품을 포함한 제품 맵핑 자료를 엑셀 파일로 제공합니다.

글로벌 심부정맥질환 치료기기 시장 보고서는 약 47개의 표, 48개의 그림, 176페이지 분량입니다.
주요 대상 고객 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자은행
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Global deep venous disease treatment devices market reached US$ XX million in 2022 and is expected to reach US$ XX million by 2030, growing at a CAGR of XX% during the forecast period 2023-2030.
A deep-vein thrombosis (DVT) is a blood clot that forms within the deep veins, usually of the leg, but can occur in the arms and the mesenteric and cerebral veins. Venous insufficiency and other vein conditions can be acute, or they can last for months or years as a chronic condition.
Deep vein disease treatment devices have been introduced to treat the conditions and clots associated with the veins. These devices include venous stents, catheters, filters, compression stockings, and others. These devices play a major role in preventing and managing deep venous diseases.
Market Dynamics: Drivers & Restraints
Increase in the prevalence of the disease
An increase in the elderly population is expected to drive the market growth. Increasing age will increase the complications. Deep venous thrombosis occurs at any age but is most common in aged population over the age of 60. Deep vein thrombosis (DVT) is a condition in which a blood clot develops in the deep veins, usually in the lower extremities.
Pulmonary embolism (PE) occurs when a part of the DVT clot breaks off and travels to the lungs, which can be life-threatening. A PE occurs when a clot breaks loose and travels through the bloodstream to the lungs.
It is estimated that 300,000 to 600,000 Americans are affected each year by venous thromboembolism, making it the third leading vascular diagnosis behind heart attack and stroke, and the leading cause of death due to major orthopedic surgery.
Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE), occurs in about 1 in 1,000 persons each year. Incidence rises with age to at least 5 in 1,000 persons in those aged greater than 80. Thus, the above factors are expected to drive the market growth.
Restraint
Increase in the preferences for drug-based treatment
Drug-based treatment provides several alternatives when compared to invasive procedures thus reducing the demand for devices. Based on the severity of the condition individuals suffering from deep venous disease will often choose drugs to recover fast when compared to the expensive procedures.
Segment Analysis
The global deep venous disease treatment devices market is segmented based on device type, end-user, and region.
Venous Stents segment accounted for 38.4% of the market share
The increase in the technological advancements in the devices and the increase in the approvals of the devices are expected to hold the segment in the dominant position. For instance, in January 2023, Penumbra, Inc. announced the U.S. Food and Drug Administration (FDA) clearance and launch of Lightning Flash, the most advanced and powerful mechanical thrombectomy system on the market. Lightning Flash features Penumbra's novel Lightning Intelligent Aspiration technology, now with dual clot detection algorithms.
In October 2020, Medtronic plc announced it had received U.S. Food and Drug Administration (FDA) approval for the Abre venous self-expanding stent system. This device is indicated for use in the iliofemoral veins in patients with symptomatic iliofemoral venous outflow obstruction, also known as deep venous obstruction. Thus, the above factors are expected to drive the market growth.
Geographical Analysis
North America is expected to hold a significant position in the global deep venous disease treatment devices market share
The increase in technological advancements, increase in device approvals and the rise in the number of patients suffering from deep venous disease in the region are expected to drive the market growth.
Deep-vein thrombosis and pulmonary emboli are common conditions. According to the report by NIH in 2023, the incidence and prevalence of DVT are estimated to be 80 cases per 100,000, with a prevalence of lower limb DVT of 1 case per 1000 population in the United States
Annually in the United States, more than 200,000 people develop venous thrombosis, of those, 50,000 cases are complicated by pulmonary embolism. Thus, the increase in the prevalence of the disease conditions is expected to drive the market growth in the region.
COVID-19 Impact Analysis
COVID-19 has had a moderate impact on the growth of the market. The device manufacturing companies have been closed due to the lockdown imposed by the government. The shift of the medical companies has shifted their focus to the manufacturing of COVID-19 medication. Thus, COVID-19 has impacted the market growth.
Market Segmentation
By Device Type
• Ablation Devices
• Venous Stents
• Venous Closure Products
• Sclerotherapy Injection
• Vena Cava Filter
• Others
By End-User
• Hospitals
• Ambulatory Surgical Centers
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The leading companies with a significant market share include Medtronic Plc, Vesper Medical Inc., enVVeno Medical Corporation, Inari Medical, Cook Medical and Boston Scientific Corporation among others.
Why Purchase the Report?
• To visualize the global deep venous disease treatment devices market segmentation based on device type, end-user, and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of deep venous disease treatment devices market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global deep venous disease treatment devices market report would provide approximately 47 tables, 48 figures, and 176 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Device Type
3.2. Snippet by End-User
3.3. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increase in the prevalence of the disease
4.1.1.2. XX
4.1.2. Restraints
4.1.2.1. Increase in the preferences for drug-based treatment
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Device Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
7.1.2. Market Attractiveness Index, By Device Type
7.2. Ablation Devices*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Venous Stents
7.4. Venous Closure Products
7.5. Sclerotherapy Injection
7.6. Vena Cava Filter
7.7. Others
8. By End-User
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals *
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Ambulatory Surgical Centers
8.4. Specialty Clinics
8.5. Others
9. By Region
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.5.1. U.S.
9.2.5.2. Canada
9.2.5.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.5.1. Germany
9.3.5.2. UK
9.3.5.3. France
9.3.5.4. Italy
9.3.5.5. Spain
9.3.5.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.5.1. Brazil
9.4.5.2. Argentina
9.4.5.3. Rest of South America
9.5. Asia-Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.5.1. China
9.5.5.2. India
9.5.5.3. Japan
9.5.5.4. Australia
9.5.5.5. Rest of Asia-Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10. Competitive Landscape
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. Company Profiles
11.1. Medtronic Plc *
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Financial Overview
11.1.4. Key Developments
11.2. Vesper Medical Inc.
11.3. enVVeno Medical Corporation
11.4. Inari Medical
11.5. Cook Medical
11.6. Boston Scientific Corporation
LIST NOT EXHAUSTIVE
12. Appendix
12.1. About Us and Services
12.2. Contact Us

언급된 주요 기업들

Medtronic Plc, 4.	Key Developments, Vesper Medical Inc., enVVeno Medical Corporation, Inari Medical, Cook Medical, Boston Scientific Corporation

표 목록 (Tables)

List of Tables

Table 1 Global Deep Venous Disease Treatment Devices Market Value, By Device Type, 2022, 2026 & 2030 (US$ Million)

Table 2 Global Deep Venous Disease Treatment Devices Market Value, By End-User, 2022, 2026 & 2030 (US$ Million)

Table 3 Global Deep Venous Disease Treatment Devices Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 4 Global Deep Venous Disease Treatment Devices Market Value, By Device Type, 2022, 2026 & 2030 (US$ Million)

Table 5 Global Deep Venous Disease Treatment Devices Market Value, By Device Type, 2021-2030 (US$ Million)

Table 6 Global Deep Venous Disease Treatment Devices Market Value, By End-User, 2022, 2026 & 2030 (US$ Million)

Table 7 Global Deep Venous Disease Treatment Devices Market Value, By End-User, 2021-2030 (US$ Million)

Table 8 Global Deep Venous Disease Treatment Devices Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 9 Global Deep Venous Disease Treatment Devices Market Value, By Region, 2021-2030 (US$ Million)

Table 10 North America Deep Venous Disease Treatment Devices Market Value, By Device Type, 2021-2030 (US$ Million)

Table 11 North America Deep Venous Disease Treatment Devices Market Value, By End-User, 2021-2030 (US$ Million)

Table 12 North America Deep Venous Disease Treatment Devices Market Value, By Country, 2021-2030 (US$ Million)

Table 13 South America Deep Venous Disease Treatment Devices Market Value, By Device Type, 2021-2030 (US$ Million)

Table 14 South America Deep Venous Disease Treatment Devices Market Value, By End-User, 2021-2030 (US$ Million)

Table 15 South America Deep Venous Disease Treatment Devices Market Value, By Country, 2021-2030 (US$ Million)

Table 16 Europe Deep Venous Disease Treatment Devices Market Value, By Device Type, 2021-2030 (US$ Million)

Table 17 Europe Deep Venous Disease Treatment Devices Market Value, By End-User, 2021-2030 (US$ Million)

Table 18 Europe Deep Venous Disease Treatment Devices Market Value, By Country, 2021-2030 (US$ Million)

Table 19 Asia-Pacific Deep Venous Disease Treatment Devices Market Value, By Device Type, 2021-2030 (US$ Million)

Table 20 Asia-Pacific Deep Venous Disease Treatment Devices Market Value, By End-User, 2021-2030 (US$ Million)

Table 21 Asia-Pacific Deep Venous Disease Treatment Devices Market Value, By Country, 2021-2030 (US$ Million)

Table 22 Middle East & Africa Deep Venous Disease Treatment Devices Market Value, By Device Type, 2021-2030 (US$ Million)

Table 23 Middle East & Africa Deep Venous Disease Treatment Devices Market Value, By End-User, 2021-2030 (US$ Million)

Table 24 Medtronic Plc: Overview

Table 25 Medtronic Plc: Product Portfolio

Table 26 Medtronic Plc: Key Developments

Table 27 Vesper Medical Inc.: Overview

Table 28 Vesper Medical Inc.: Product Portfolio

Table 29 Vesper Medical Inc.: Key Developments

Table 30 enVVeno Medical Corporation: Overview

Table 31 enVVeno Medical Corporation: Product Portfolio

Table 32 enVVeno Medical Corporation: Key Developments

Table 33 Inari Medical: Overview

Table 34 Inari Medical: Product Portfolio

Table 35 Inari Medical: Key Developments

Table 36 Cook Medical: Overview

Table 37 Cook Medical: Product Portfolio

Table 38 Cook Medical: Key Developments

Table 39 Boston Scientific Corporation: Overview

Table 40 Boston Scientific Corporation: Product Portfolio

Table 41 Boston Scientific Corporation: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Deep Venous Disease Treatment Devices Market Value, 2021-2030 (US$ Million)

Figure 2 Global Deep Venous Disease Treatment Devices Market Share, By Device Type, 2022 & 2030 (%)

Figure 3 Global Deep Venous Disease Treatment Devices Market Share, By End-User, 2022 & 2030 (%)

Figure 4 Global Deep Venous Disease Treatment Devices Market Share, By Region, 2022 & 2030 (%)

Figure 5 Global Deep Venous Disease Treatment Devices Market Y-o-Y Growth, By Device Type, 2022-2030 (%)

Figure 6 Ablation Devices Deep Venous Disease Treatment Devices Market Value, 2021-2030 (US$ Million)

Figure 7 Venous Stents Deep Venous Disease Treatment Devices Market Value, 2021-2030 (US$ Million)

Figure 8 Venous Closure Products Deep Venous Disease Treatment Devices Market Value, 2021-2030 (US$ Million)

Figure 9 Sclerotherapy Injection Deep Venous Disease Treatment Devices Market Value, 2021-2030 (US$ Million)

Figure 10 Vena Cava Filter Deep Venous Disease Treatment Devices Market Value, 2021-2030 (US$ Million)

Figure 11 Others Deep Venous Disease Treatment Devices Market Value, 2021-2030 (US$ Million)

Figure 12 Global Deep Venous Disease Treatment Devices Market Y-o-Y Growth, By End-User, 2022-2030 (%)

Figure 13 Hospitals End-User in Global Deep Venous Disease Treatment Devices Market Value, 2021-2030 (US$ Million)

Figure 14 Ambulatory Surgical Centers End-User in Global Deep Venous Disease Treatment Devices Market Value, 2021-2030 (US$ Million)

Figure 15 Specialty Clinics End-User in Global Deep Venous Disease Treatment Devices Market Value, 2021-2030 (US$ Million)

Figure 16 Others End-User in Global Deep Venous Disease Treatment Devices Market Value, 2021-2030 (US$ Million)

Figure 17 Global Deep Venous Disease Treatment Devices Market Y-o-Y Growth, By Region, 2022-2030 (%)

Figure 18 North America Deep Venous Disease Treatment Devices Market Value, 2021-2030 (US$ Million)

Figure 19 Asia-Pacific Deep Venous Disease Treatment Devices Market Value, 2021-2030 (US$ Million)

Figure 20 Europe Deep Venous Disease Treatment Devices Market Value, 2021-2030 (US$ Million)

Figure 21 South America Deep Venous Disease Treatment Devices Market Value, 2021-2030 (US$ Million)

Figure 22 Middle East and Africa Deep Venous Disease Treatment Devices Market Value, 2021-2030 (US$ Million)

Figure 23 North America Deep Venous Disease Treatment Devices Market Value, 2021-2030 (US$ Million)

Figure 24 North America Deep Venous Disease Treatment Devices Market Share, By Device Type, 2022 & 2030 (%)

Figure 25 North America Deep Venous Disease Treatment Devices Market Share, By End-User, 2022 & 2030 (%)

Figure 26 North America Deep Venous Disease Treatment Devices Market Share, By Country, 2022 & 2030 (%)

Figure 27 South America Deep Venous Disease Treatment Devices Market Value, 2021-2030 (US$ Million)

Figure 28 South America Deep Venous Disease Treatment Devices Market Share, By Device Type, 2022 & 2030 (%)

Figure 29 South America Deep Venous Disease Treatment Devices Market Share, By End-User, 2022 & 2030 (%)

Figure 30 South America Deep Venous Disease Treatment Devices Market Share, By Country, 2022 & 2030 (%)

Figure 31 Europe Deep Venous Disease Treatment Devices Market Value, 2021-2030 (US$ Million)

Figure 32 Europe Deep Venous Disease Treatment Devices Market Share, By Device Type, 2022 & 2030 (%)

Figure 33 Europe Deep Venous Disease Treatment Devices Market Share, By End-User, 2022 & 2030 (%)

Figure 34 Europe Deep Venous Disease Treatment Devices Market Share, By Country, 2022 & 2030 (%)

Figure 35 Asia-Pacific Deep Venous Disease Treatment Devices Market Value, 2021-2030 (US$ Million)

Figure 36 Asia-Pacific Deep Venous Disease Treatment Devices Market Share, By Device Type, 2022 & 2030 (%)

Figure 37 Asia-Pacific Deep Venous Disease Treatment Devices Market Share, By End-User, 2022 & 2030 (%)

Figure 38 Asia-Pacific Deep Venous Disease Treatment Devices Market Share, By Country, 2022 & 2030 (%)

Figure 39 Middle East & Africa Deep Venous Disease Treatment Devices Market Value, 2021-2030 (US$ Million)

Figure 40 Middle East & Africa Deep Venous Disease Treatment Devices Market Share, By Device Type, 2022 & 2030 (%)

Figure 41 Middle East & Africa Deep Venous Disease Treatment Devices Market Share, By End-User, 2022 & 2030 (%)

Figure 42 Medtronic Plc: Financials

Figure 43 Vesper Medical Inc.: Financials

Figure 44 enVVeno Medical Corporation: Financials

Figure 45 Inari Medical: Financials

Figure 46 Cook Medical: Financials

Figure 47 Boston Scientific Corporation: Financials

세계 심부정맥질환 치료기기 시장 – 2023-2030

Global Deep Venous Disease Treatment Devices Market - 2023-2030